Cetuximab (Erbitux; ImClone Inc.), a 152 kDa chimeric monoclonal antibody of the immunoglobulin G1 subclass that binds to the extracellular domain of the human EGFR [20], has been used to treat GBM [21]. This evidence concerns the gene EGFR and glioblastoma.